Commissioning statements


Commissioning Statement Process – updated August 2018

The following commissioning statements have been agreed by the members of the South West Yorkshire Area Prescribing Committee:


(n) = new
(a) = amendment
Antioxidant Vitamins in Age related Macular Degeneration (AMD)NHSE
Not routinely commissioned in Primary Care
Botulinum Toxin Type ABotulinum16th January 2015Awaiting RMOC decision
Brimonidine gel (for treatment of facial erythema of rosacea in adults)Brimonidine27th September 2019September 202127th September 2019 (a)
Dapoxetinedapoxetine November 2016January 2020
Flash Glucose MonitoringWY&H Flash Glucose 1st May 2019May 2022
Glucosamine or Chondroitin productsNHSE guidance
Not routinely commissioned in Primary Care
Herbal medicines and health supplementsNHSE guidance
Not routinely commissioned in Primary Care
Homeopathic MedicinesNHSE guidance
Not routinely commissioned in Primary Care
Hyaluronic Acid and its derivatives (injectables) - for the treatment of osteoarthritis and other joint conditions)Hyaluronic1st September 2018September 2021
Hydrocortisone tabletshydrocortisone November 2019November 202227th November 2019 (a)
Licensed E-cigarettese-cigarettes 10th October 2017October 2020
Linaclotide TabletsNHSE guidance
Liothyronine ArmourWY&H Liothyronine Commissioning Statement20th May 2019April 2021
Liraglutide (for Obesity)Liraglutide 10th October 2017October 2020
Medicines for dental conditions on FP10 prescriptionBlack with the exception of those patients on specialist advice following treatment for head and neck cancers (GSI)
NHSE guidance
Not routinely commissioned in Primary Care
June 2019Updated Sept 2020
NefopamNefopamNovember 2019November 2022
Phosphodiesterase type-5 inhibitors (for treatment of penile rehabilitation post radical prostatectomy or radiotherapy)Replaced by Sildenafil1st January 2019March 2022
Rituximab for RA without methotrexateRituximab 23rd May 2017April 2020
SildenafilSildenafil1st January 2019March 2022
Silicone scar gels and sheets - for healing skin (not open wounds) to reduce redness and try to minimise hypertrophic or keloid scarsSilicone November 2019November 2022
Silk GarmentsNHSE guidance
Not routinely commissioned in Primary Care
Tocilizumab SC (for Treatment of Rheumatoid Arthritis/Active Systemic Juvenile Idiopathic Arthritis)Tocilizumab2nd October 2014March 2022
Trans-anal Irrigation SystemsTrans-anal 11th September 2017May 2021
Travel MedicinesNHSE guidance
Not routinely commissioned in Primary Care
VibropulseVibropulse18th March 2020 (n)March 2023


The member CCGs do not routinely commission or fund medicines for dental conditions on GP FP10 prescription except in the following circumstances:

  • Where the GP is the responsible clinician for assessing and monitoring the effectiveness of treatment
  • For emergency treatment of patients unable to access a dentist
  • After head and neck cancer treatment on the recommendation of a Head and Neck or Restorative Dental Consultant



Flash Glucose Monitoring – Updated July 2019

We have been working with diabetes specialists in West Yorkshire and Harrogate to update our policies on flash glucose monitoring, following the publication of new guidance from NHS England, and to agree a single policy for all nine clinical commissioning groups.

A Flash Glucose commissioning policy for West Yorkshire and Harrogate has been approved and will start to implement the NHS England guidance regarding “Flash Glucose Monitoring: National Arrangements for Funding of Relevant Diabetes Patients.”  The Diabetes Specialist Teams in local areas will be responsible for assessing whether patients meet the criteria in this guidance, starting flash glucose monitoring and ongoing review.  The continued  supply of the flash glucose monitoring sensors will transfer to the patients GP practice.

There are available adult and paediatric patient agreement forms for Flash Glucose Monitoring here.


Conditions for over the counter items should not routinely be prescribed

Following the publication of the above NHSE guidance to CCGs; the SWYAPC CCGs intend to commission in line with the guidance and align the Commissioning Statements.

The SWYAPC have produced a letter to inform Community Pharmacies in Bradford, Calderdale, Kirklees and Wakefield of the local plans regarding the NHSE guidance.